| Literature DB >> 35547370 |
Philipp Balcerak1, Sydney Corbiere1, Richard Zubal1, Georg Kägi1,2.
Abstract
Purpose: Post-stroke dysphagia is an underdiagnosed but relevant complication, associated with worse outcome, dependency and quality of life of stroke survivors. Detailed mechanisms of post-stroke dysphagia are not very well understood, but established therapeutic concepts are needed. Different interventional studies have been published dealing with post-stroke dysphagia. This systematic review wants to collect and give an overview over the published evidence.Entities:
Keywords: cerebrovascular; deglutition; ischemia; nutrition; swallowing; therapy
Year: 2022 PMID: 35547370 PMCID: PMC9082350 DOI: 10.3389/fneur.2022.823189
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1Flow diagram on literature retrieval.
Summary of results.
|
|
|
|
| |
|---|---|---|---|---|
|
| ||||
| Chen ( | Acupuncture | 250 | •Bedside swallowing test | Enhanced recovery |
| Xia ( | Acupuncture + usual care | 124 | •SSA | Enhanced recovery (in the later course of follow-up) |
|
| ||||
| Carnaby ( | Physical therapy in different intensity levels | 306 | Paramatta Hospital's assessment of dysphagia | Intensity-level dependent Enhanced recovery |
| Eom ( | Expiratory muscle strength training | 33 | •VDS | Enhanced recovery |
| Guillen-Sola ( | Respiratory muscle strength training | 42 (60 in total w/ NMES) | •FOIS | Enhance recovery (both interventional groups) |
| Heo ( | Kinesio taping | 44 | FDS | No difference |
| Hwang ( | Tongue stretching exercises | 25 | VFS | Enhanced recovery |
| Kim ( | Tongue-to-palate-resistance-training | 35 | •VFS/DS | Improvement on VFS, but not PAS |
| Koyama ( | Jaw opening exercise | 16 | •VFS | No difference in clinical evaluation, mixed results for instrumental scales |
| Li ( | Extended and standardized behavioral and physical training (partly including acupuncture and electrical stimulation) | 40 | Kubota water swallowing test | Enhanced recovery |
| Moon ( | Expiratory muscle strength training | 18 | •PAS | Enhanced recovery |
| Moon ( | Tongue pressure strength and accuracy training | 16 | MASA | Enhanced recovery |
| Park ( | Effortful swallowing training | 24 | VDS | Enhanced recovery |
| Park ( | Jaw opening exercise | 40 | •PAS | No difference |
| Park ( | Chin tuck against resistance exercise | 22 | •FDS | Enhanced recovery |
|
| ||||
| Cui ( | Oral capsaicin + ice stimulation | 92 | •WST | Enhanced recovery |
| Feng ( | Tongyan spray | 122 | SSA | Enhanced recovery |
| Lee ( | Lisinopril | 93 | Royal Brisbane Hospital Outcome Measure for Swallowing | No difference |
| Perez ( | Nifedipine | 17 | •VFS | Enhanced recovery |
| Wang ( | Capsaicin | 69 | •Volume-Viscosity Swallow Test | Enhanced recovery |
|
| ||||
| Carnaby ( | McNeill Dysphagia Therapy + neuromuscular electrical stimulation | 53 | •MASA | Dysphagia improvement from physical therapy and NMES |
| Guillen-Sola ( | NMES | 41 (60 in total w/ NMES) | •FOIS | Enhance recovery (both interventional groups) |
| Huang ( | NMES or NMES + usual care | 29 | •FOIS | Mixed results without clear significant effect |
| Konecny ( | NMES hyoid | 108 | •VFS | Enhanced recovery |
| Lim ( | NMES | 33 (47 total w/ rTMS) | •PAS | Enhanced recovery with limitations: only first follow-up, liquids and instrumental scores |
| Power ( | Faucial pillar stimulation | 16 | •PAS | No difference |
| Umay ( | Sensory-level electric stimulation of masseter | 98 | •MASA | Enhanced recovery |
| Xia ( | NMES or NMES + usual care | 120 | •VFS | Only dysphagia improvement in NMES + usual care |
| Lee ( | NMES + usual care | 57 | •FOIS | Enhanced recovery |
|
| ||||
| Bath ( | PES | 162 | •VFS | No difference |
| Dziewas ( | PES | 69 | •FEES | Dysphagia improvement, more decannulations |
| Jayasekeran ( | PES | 28 | •VFS/PAS | Enhanced recovery |
| Vasant ( | PES | 36 | •Dysphagia severity rating scale | No difference |
|
| ||||
| Kumar ( | tDCS | 14 | •DOSS | Enhanced recovery |
| Pingue ( | tDCS | 40 | •DOSS | No difference |
| Suntrup-Krueger ( | tDCS | 60 | •Fiberoptic Endoscopic Dysphagia Severity Scale | Enhanced recovery |
| Yang ( | tDCS | 16 | •FDS | Enhanced recovery |
|
| ||||
| Du ( | rTMS high- and low-intensity | 40 | •SSA | Enhanced recovery |
| Khedr ( | rTMS | 22 | •WST | Enhanced recovery |
| Lim ( | rTMS | 29 (47 total w/ NMES) | •PAS | Enhanced recovery with limitations: only first follow-up, liquids and instrumental scores |
| Tarameshlu ( | rTMS + usual care and rTMS | 18 | •MASA | Enhanced recovery only for combined therapy |
| Khedr ( | rTMS | 26 | •WST | Enhanced recovery |
| Park ( | Bilateral rTMS, unilateral rTMS | 35 | •Clinical Dysphagia Scale | Enhanced recovery only for bilateral rTMS |
Summary of study characteristics. Summary of results show the statistical results as to the rejection of H
These studies used three arms with usual care being one of those, that is why these studies are listed in two interventional groups.
Summary of risk of bias assessment.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
| ||||||
| Chen ( | - | + | + | - | - | + |
| Xia ( | O | + | - | - | - | + |
|
| ||||||
| Carnaby ( | - | + | - | - | - | + |
| Eom ( | O | - | O | - | - | O |
| Guillen-Sola ( | - | - | O | - | - | O |
| Heo ( | O | O | - | + | - | + |
| Hwang ( | - | + | + | - | - | + |
| Kim ( | O | + | O | - | - | + |
| Koyama ( | - | O | + | - | - | + |
| Li ( | + | + | - | o | - | + |
| Moon ( | O | O | - | - | - | O |
| Moon ( | - | + | + | 0 | - | + |
| Park ( | - | + | + | - | - | + |
| Park ( | - | + | - | - | - | + |
| Park ( | - | + | O | - | - | + |
|
| ||||||
| Cui ( | - | + | + | O | - | + |
| Feng ( | - | O | - | O | - | O |
| Lee ( | - | - | + | - | - | + |
| Perez ( | - | - | - | - | - | - |
| Wang ( | - | - | O | - | - | O |
|
| ||||||
| Carnaby ( | - | + | - | - | - | + |
| Guillen-Sola ( | - | O | O | - | - | O |
| Huang ( | O | + | - | - | - | + |
| Konecny ( | O | + | - | - | - | + |
| Lim ( | O | O | O | - | - | + |
| Power ( | O | O | O | - | - | + |
| Umay ( | - | O | O | - | - | O |
| Xia ( | O | O | - | - | - | O |
| Lee ( | - | O | - | - | - | O |
|
| ||||||
| Bath ( | O | O | - | - | - | O |
| Dziewas ( | - | - | + | - | - | + |
| Jayasekeran ( | - | O | - | - | - | - |
| Vasant ( | - | - | - | - | - | - |
|
| ||||||
| Kumar ( | - | O | O | - | - | O |
| Pingue ( | - | O | - | - | - | - |
| Suntrup-Krueger ( | - | - | - | - | - | - |
| Yang ( | O | O | - | - | - | O |
|
| ||||||
| Du ( | - | - | - | - | - | - |
| Khedr ( | O | O | - | - | - | O |
| Lim ( | O | O | O | - | - | + |
| Tarameshlu ( | - | O | - | - | - | O |
| Khedr ( | O | - | - | - | - | O |
| Park ( | O | O | - | - | - | O |
Risk of Bias assessment. Overview over consensus result of the risk of bias assessment, using the risk-of-bias-tool-2 according to Cochrane's handbook. – low risk, 0 some concerns or unclear risk, + high risk. Overall risk assessment according to RoB-2-algorithm.
These studies used three arms with usual care being one of those. That is why these studies are listed in two interventional groups.